In conclusion, we exclude that TUS could reliably replace CXR, and we confirm that the assessment of physical signs, CXR, and biomarkers such as procalcitonin and CRP, remain the pillars for the diagnosis of pneumonia. This evidence concerns the gene CRP and pneumonia.